Corcept Therapeutics, Inc. (CORT)
43.96
+0.06
(+0.14%)
USD |
NASDAQ |
Apr 16, 16:00
43.98
+0.02
(+0.03%)
After-Hours: 20:00
Corcept Therapeutics Free Cash Flow : 141.78M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 12.36B |
| Terns Pharmaceuticals, Inc. | -82.18M |
| Integer Holdings Corp. | 105.12M |
| Ultragenyx Pharmaceutical, Inc. | -487.00M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 38.45M |
| Cash from Investing (Quarterly) | -11.84M |
| Cash from Financing (Quarterly) | -31.22M |
| Free Cash Flow Per Share (Quarterly) | 0.3204 |
| Free Cash Flow to Equity (Quarterly) | 38.65M |
| Free Cash Flow to Firm (Quarterly) | 38.40M |
| Free Cash Flow Yield | 2.69% |